Durysta

— THERAPEUTIC CATEGORIES —
  • Glaucoma

Durysta Generic Name & Formulations

General Description

Bimatoprost 10mcg; per implant; for intracameral administration.

Pharmacological Class

Prostaglandin analogue.

How Supplied

Implant—1 (w. applicator)

Manufacturer

Generic Availability

NO

Durysta Indications

Indications

Reduction of intraocular pressure in open-angle glaucoma or ocular hypertension.

Durysta Dosage and Administration

Adult

See full labeling. Perform intracameral inj procedure under magnification as directed.

Children

Not established.

Durysta Contraindications

Contraindications

Ocular or periocular infections. Corneal endothelial cell dystrophy (eg, Fuchs' Dystrophy). Prior corneal transplantation or endothelial cell transplants (eg, Descemet's Stripping Automated Endothelial Keratoplasty). Absent or ruptured posterior lens capsule.

Durysta Boxed Warnings

Not Applicable

Durysta Warnings/Precautions

Warnings/Precautions

Limited corneal endothelial cell reserve. Narrow iridocorneal angles (Shaffer grade <3). Anatomical obstruction (eg, scarring). Aphakia. Pseudophakia with torn posterior lens capsule. Risk factors for macular edema. Active intraocular inflammation (eg, uveitis). Increased iris pigmentation: evaluate regularly. Endophthalmitis. Pregnancy. Nursing mothers.

Durysta Pharmacokinetics

See Literature

Durysta Interactions

Not Applicable

Durysta Adverse Reactions

Adverse Reactions

Conjunctival hyperemia, foreign body sensation, eye pain/irritation, photophobia, conjunctival hemorrhage, dry eye, intraocular pressure increased, corneal endothelial cell loss, vision blurred, iritis, headache.

Durysta Clinical Trials

See Literature

Durysta Note

Not Applicable

Durysta Patient Counseling

See Literature